TOUR [Tuniu] CORRESP: (Original Filing)

[Morgan Stanley & Co. International plc Credit Suisse Securities (USA) LLC China Renaissance Securities (Hong Kong) Limited 25 Cabot Square, Canary Wharf London E14 4QA United Kingdom Eleven Madison Avenue New York, New York 10010-3629 U.S.A. Unit 901, Agricultural Bank of China Tower 50 Connaught Road Central, Central Hong Kong VIA EDGAR AND FACSIMILE May 6, 2014 Division of Corporation]

By | 2016-03-18T07:17:15+00:00 May 6th, 2014|Categories: Chinese Stocks, SEC Original, TOUR|Tags: , , , , , |0 Comments

JMEI [Jumei International] F-6:

[] [] [Writer’s Direct Dial Emmet, Marvin & Martin, LLP Counsellors at Law _____ 120 Broadway New York, New York 10271 _____ (212) 238-3000 (212) 653-1760 _____ Fax: (212) 238-3100 Fax: (212) 653-1730 http://www.emmetmarvin.com 177 Madison Avenue Morristown, New Jersey 07960 (973) 538-5600 Fax: (973) 538-6448 May 6, 2014 The Bank of New York Mellon, as Depositary 101 Barclay Street New York,]

By | 2016-03-22T12:28:53+00:00 May 6th, 2014|Categories: Chinese Stocks, JMEI, Webplus ver|Tags: , , , , , |0 Comments

TOUR [Tuniu] CORRESP: Morgan Stanley & Co. International plc Credit Suisse

[Morgan Stanley & Co. International plc Credit Suisse Securities (USA) LLC China Renaissance Securities (Hong Kong) Limited 25 Cabot Square, Canary Wharf London E14 4QA United Kingdom Eleven Madison Avenue New York, New York 10010-3629 U.S.A. Unit 901, Agricultural Bank of China Tower 50 Connaught Road Central, Central Hong Kong VIA EDGAR AND FACSIMILE May 6, 2014 Division of Corporation]

By | 2016-03-18T07:18:40+00:00 May 6th, 2014|Categories: Chinese Stocks, TOUR, Webplus ver|Tags: , , , , , |0 Comments

CBPO [China Biologic Products] 8-K: (Original Filing)

[FOR RELEASE May 6, 2014 China Biologic Reports Financial Results for the First Quarter of 2014 1Q14 Total Sales Increase 4.1% to $56.3Million 1Q14 Operating Margin Increases to 49.7% from 1Q14 Non-GAAP Net Income Increases 16.3% to $ 19.1Million BEIJING, China – May 6, 2014 – First Quarter 2014 Financial Highlights · Total sales · Gross profit · Income from] []

TOUR [Tuniu] CORRESP: May 6, 2014 VIA EDGAR AND FACSIMILE Division

[May 6, 2014 VIA EDGAR AND FACSIMILE Division of Corporation Finance 100 F Street, N.E. Attention: Mr. Justin Dobbie Mr. J. Nolan McWilliams Mr. Doug Jones Mr. Stephen Kim Re: Tuniu Corporation Registration Statement on Form F-1 (Registration No. 333-195075) Registration Statement on Form 8-A (Registration No. 001-36430) Dear Ladies and Gentlemen: If there is any change in the acceleration]

By | 2016-03-18T07:21:22+00:00 May 6th, 2014|Categories: Chinese Stocks, TOUR, Webplus ver|Tags: , , , , , |0 Comments

CBPO [China Biologic Products] 8-K: FOR RELEASE May 6, 2014 China Biologic Reports

[FOR RELEASE May 6, 2014 China Biologic Reports Financial Results for the First Quarter of 2014 1Q14 Total Sales Increase 4.1% to $56.3Million 1Q14 Operating Margin Increases to 49.7% from 1Q14 Non-GAAP Net Income Increases 16.3% to $ 19.1Million BEIJING, China – May 6, 2014 – First Quarter 2014 Financial Highlights · Total sales · Gross profit · Income from] []

TOUR [Tuniu] CORRESP: (Original Filing)

[KADDEN RPS LATE EAGHER LOM S ARTNERS P OHN DEBIYI ¿ J HRISTOPHER ETTS C DWARD AM ¿ E AUL ITCHARD ¿ G.S. P LIVE OUGH ¿ C ONATHAN TONE J LEC RACY A ¿ LSO DMITTED IN NGLAND ALES LSO DMITTED IN EW ORK * (A EGISTERED OREIGN AWYERS R ILL AI ALIFORNIA W ULIE AO ALIFORNIA Z. J]

By | 2016-03-18T07:22:33+00:00 May 6th, 2014|Categories: Chinese Stocks, SEC Original, TOUR|Tags: , , , , , |0 Comments

CBPO [China Biologic Products] 10-Q: (Original Filing)

[] [CERTIFICATIONS I, David (Xiaoying) Gao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Ming Yang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th David (Xiaoying) Gao Chief Executive Officer] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th Ming Yang Chief Financial Officer (Principal Financial Officer)]

TOUR [Tuniu] CORRESP: KADDEN RPS LATE EAGHER LOM S ARTNERS P

[KADDEN RPS LATE EAGHER LOM S ARTNERS P OHN DEBIYI ¿ J HRISTOPHER ETTS C DWARD AM ¿ E AUL ITCHARD ¿ G.S. P LIVE OUGH ¿ C ONATHAN TONE J LEC RACY A ¿ LSO DMITTED IN NGLAND ALES LSO DMITTED IN EW ORK * (A EGISTERED OREIGN AWYERS R ILL AI ALIFORNIA W ULIE AO ALIFORNIA Z. J]

By | 2016-03-18T07:23:37+00:00 May 6th, 2014|Categories: Chinese Stocks, TOUR, Webplus ver|Tags: , , , , , |0 Comments

CBPO [China Biologic Products] 10-Q:

[] [CERTIFICATIONS I, David (Xiaoying) Gao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Ming Yang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th David (Xiaoying) Gao Chief Executive Officer] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th Ming Yang Chief Financial Officer (Principal Financial Officer)]

Skip to toolbar